Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Jun;33(6):1510–1515. doi: 10.1128/jcm.33.6.1510-1515.1995

Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmission.

T Yamamoto 1, K Terada 1, N Nishida 1, R Moriuchi 1, S Shirabe 1, T Nakamura 1, Y Tsuji 1, T Miyamoto 1, S Katamine 1
PMCID: PMC228205  PMID: 7650176

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) is known to be transmitted vertically through breastfeeding and horizontally by blood transfusion and sexual contact. Our intervention study has suggested the presence of additional alternative maternal transmission pathways. To explore the possibility of transmission through saliva, we used PCR to quantify the HTLV-1 provirus in saliva samples from 18 carrier mothers and 10 patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. The provirus was detected in 60 and 90%, respectively, of the samples, with estimated copy numbers in the range of 10 to 10(4)/ml. However, the saliva, regardless of the presence or absence of antibodies to the virus, showed a strong tendency to inhibit the cell-to-cell transmission of HTLV-1 in vitro, as examined by a syncytium inhibition assay. The natural inhibitory activity in saliva of seronegative volunteers was heat sensitive, and most of the activity was recovered by ultrafiltration in the fraction of macromolecules with a molecular weight of more than 100,000. In addition to this natural activity, saliva of HTLV-1-infected individuals contained immunoglobulin G molecules capable of neutralizing syncytium formation. These results strongly suggested that HTLV-1-infected cells in the carriers' saliva, which contains neutralizing antibodies in addition to the natural activity inhibiting cell-to-cell viral infection, barely transmit the virus. Transmission of HTLV-1 through the saliva would thus seem to be rare, if it occurs at all.

Full Text

The Full Text of this article is available as a PDF (278.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Delamarre L., Pique C., Pham D., Tursz T., Dokhélar M. C. Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein. J Virol. 1994 Jun;68(6):3544–3549. doi: 10.1128/jvi.68.6.3544-3549.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fox P. C., Wolff A., Yeh C. K., Atkinson J. C., Baum B. J. Saliva inhibits HIV-1 infectivity. J Am Dent Assoc. 1988 May;116(6):635–637. doi: 10.14219/jada.archive.1988.0002. [DOI] [PubMed] [Google Scholar]
  3. Fox P. C., Wolff A., Yeh C. K., Atkinson J. C., Baum B. J. Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children. J Am Dent Assoc. 1989 Jun;118(6):709–711. doi: 10.14219/jada.archive.1989.0165. [DOI] [PubMed] [Google Scholar]
  4. Fujino R., Kawato K., Ikeda M., Miyakoshi H., Mizukoshi M., Imai J. Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res. 1991 Apr;82(4):367–370. doi: 10.1111/j.1349-7006.1991.tb01856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fultz P. N. Components of saliva inactivate human immunodeficiency virus. Lancet. 1986 Nov 22;2(8517):1215–1215. doi: 10.1016/s0140-6736(86)92218-x. [DOI] [PubMed] [Google Scholar]
  6. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  7. Hino S., Kawamichi T., Funakoshi M., Kanamura M., Kitamura T., Miyamoto T. Transfusion-mediated spread of the human T-cell leukemia virus in chronic hemodialysis patients in a heavily endemic area, Nagasaki. Gan. 1984 Dec;75(12):1070–1075. [PubMed] [Google Scholar]
  8. Hino S., Sugiyama H., Doi H., Ishimaru T., Yamabe T., Tsuji Y., Miyamoto T. Breaking the cycle of HTLV-I transmission via carrier mothers' milk. Lancet. 1987 Jul 18;2(8551):158–159. doi: 10.1016/s0140-6736(87)92358-0. [DOI] [PubMed] [Google Scholar]
  9. Hino S., Yamaguchi K., Katamine S., Sugiyama H., Amagasaki T., Kinoshita K., Yoshida Y., Doi H., Tsuji Y., Miyamoto T. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res. 1985 Jun;76(6):474–480. [PubMed] [Google Scholar]
  10. Hinuma Y., Komoda H., Chosa T., Kondo T., Kohakura M., Takenaka T., Kikuchi M., Ichimaru M., Yunoki K., Sato I. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer. 1982 Jun 15;29(6):631–635. doi: 10.1002/ijc.2910290606. [DOI] [PubMed] [Google Scholar]
  11. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K. I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476–6480. doi: 10.1073/pnas.78.10.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ichikawa S., Ito A. [Detection of antibodies to HIV and HIV-genes in saliva and urine]. Nihon Rinsho. 1993 Sep;51 (Suppl):299–305. [PubMed] [Google Scholar]
  13. Katamine S., Moriuchi R., Yamamoto T., Terada K., Eguchi K., Tsuji Y., Yamabe T., Miyamoto T., Hino S. HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet. 1994 May 28;343(8909):1326–1327. doi: 10.1016/s0140-6736(94)92469-4. [DOI] [PubMed] [Google Scholar]
  14. Kawase K., Katamine S., Moriuchi R., Miyamoto T., Kubota K., Igarashi H., Doi H., Tsuji Y., Yamabe T., Hino S. Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals. Jpn J Cancer Res. 1992 Sep;83(9):968–977. doi: 10.1111/j.1349-7006.1992.tb02009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Klement V., Rowe W. P., Hartley J. W., Pugh W. E. Mixed culture cytopathogenicity: a new test for growth of murine leukemia viruses in tissue culture. Proc Natl Acad Sci U S A. 1969 Jul;63(3):753–758. doi: 10.1073/pnas.63.3.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981 Dec 24;294(5843):770–771. doi: 10.1038/294770a0. [DOI] [PubMed] [Google Scholar]
  17. Miyoshi I., Sawada T., Iwahara Y., Ishii K., Kubonishi I., Taguchi H. Excretion of HTLV-I in saliva. JAMA. 1992 Jan 8;267(2):236–236. [PubMed] [Google Scholar]
  18. Murphy E. L., Figueroa J. P., Gibbs W. N., Brathwaite A., Holding-Cobham M., Waters D., Cranston B., Hanchard B., Blattner W. A. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1989 Oct 1;111(7):555–560. doi: 10.7326/0003-4819-111-7-555. [DOI] [PubMed] [Google Scholar]
  19. Nagy K., Clapham P., Cheingsong-Popov R., Weiss R. A. Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int J Cancer. 1983 Sep 15;32(3):321–328. doi: 10.1002/ijc.2910320310. [DOI] [PubMed] [Google Scholar]
  20. Nakano S., Ando Y., Ichijo M., Moriyama I., Saito S., Sugamura K., Hinuma Y. Search for possible routes of vertical and horizontal transmission of adult T-cell leukemia virus. Gan. 1984 Dec;75(12):1044–1045. [PubMed] [Google Scholar]
  21. Okochi K., Sato H., Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 1984;46(5):245–253. doi: 10.1111/j.1423-0410.1984.tb00083.x. [DOI] [PubMed] [Google Scholar]
  22. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
  23. Pique C., Pham D., Tursz T., Dokhélar M. C. Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation. J Virol. 1992 Feb;66(2):906–913. doi: 10.1128/jvi.66.2.906-913.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Popovic M., Sarin P. S., Robert-Gurroff M., Kalyanaraman V. S., Mann D., Minowada J., Gallo R. C. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science. 1983 Feb 18;219(4586):856–859. doi: 10.1126/science.6600519. [DOI] [PubMed] [Google Scholar]
  26. Spear G. T., Jiang H. X., Sullivan B. L., Gewurz H., Landay A. L., Lint T. F. Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells. AIDS Res Hum Retroviruses. 1991 Jul;7(7):579–585. doi: 10.1089/aid.1991.7.579. [DOI] [PubMed] [Google Scholar]
  27. Tajima K., Tominaga S., Suchi T., Kawagoe T., Komoda H., Hinuma Y., Oda T., Fujita K. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus. Gan. 1982 Dec;73(6):893–901. [PubMed] [Google Scholar]
  28. Terada K., Katamine S., Eguchi K., Moriuchi R., Kita M., Shimada H., Yamashita I., Iwata K., Tsuji Y., Nagataki S. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet. 1994 Oct 22;344(8930):1116–1119. doi: 10.1016/s0140-6736(94)90630-0. [DOI] [PubMed] [Google Scholar]
  29. Yamanouchi K., Kinoshita K., Moriuchi R., Katamine S., Amagasaki T., Ikeda S., Ichimaru M., Miyamoto T., Hino S. Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn J Cancer Res. 1985 Jun;76(6):481–487. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES